{
  "document_number": "2025-08266",
  "executive_order_number": "14292",
  "title": "Improving the Safety and Security of Biological Research",
  "abstract": null,
  "signing_date": "2025-05-05",
  "publication_date": "2025-05-08",
  "president": {
    "identifier": "donald-trump",
    "name": "Donald Trump"
  },
  "html_url": "https://www.federalregister.gov/documents/2025/05/08/2025-08266/improving-the-safety-and-security-of-biological-research",
  "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2025-05-08/pdf/2025-08266.pdf",
  "raw_text_url": "https://www.federalregister.gov/documents/full_text/text/2025/05/08/2025-08266.txt",
  "enrichment": {
    "summary": "This executive order directs the U.S. government to stop funding risky biological research that could make viruses or pathogens more dangerous, especially when done by foreign entities with limited oversight. It also establishes stronger rules and transparency measures to ensure that all federally funded life-science research is safe and secure, aiming to protect public health and national security.",
    "theme_ids": [
      "weapons-of-mass-destruction-wmd-proliferation",
      "biotechnology-biomanufacturing",
      "pandemic-preparedness",
      "national-security-information-classification"
    ],
    "impacted_populations": {
      "positive_ids": [
        "u-s-citizens",
        "scientific-researchers",
        "healthcare-workers"
      ],
      "negative_ids": [
        "scientific-researchers",
        "foreign-nationals-general",
        "corporations-businesses"
      ]
    },
    "potential_concerns": [
      "Restricting federally funded gain-of-function research, especially abroad, may hinder scientific researchers' ability to conduct important biotechnology work, potentially slowing innovation and public health preparedness.",
      "Cutting funding to foreign entities involved in high-risk biological research could strain international scientific collaboration and reduce global pandemic preparedness, affecting both foreign nationals and U.S. citizens indirectly.",
      "Enhanced enforcement and transparency requirements may impose administrative burdens on scientific researchers and corporations, potentially diverting resources from research to compliance rather than scientific progress.",
      "Limitations on synthetic nucleic acid procurement and strict oversight could increase operational costs for biotechnology companies, potentially impacting their competitiveness and slowing industry growth.",
      "The order's focus on security classification and enforcement may create concerns among healthcare workers and researchers about confidentiality, data sharing, and the balance between transparency and national security."
    ],
    "enriched_at": "2025-12-15T08:17:10.473Z",
    "model_used": "gpt-4.1-mini"
  }
}